Amorepacific Corporation (090430.KS)
| Previous Close | 174,300.00 |
| Open | 171,100.00 |
| Bid | 177,000.00 x 0 |
| Ask | 177,300.00 x 0 |
| Day's Range | 168,000.00 - 178,000.00 |
| 52 Week Range | 93,900.00 - 200,500.00 |
| Volume | |
| Avg. Volume | 316,439 |
| Market Cap | 10.872T |
| Beta (5Y Monthly) | 1.13 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Jul 24, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 910.00 (0.52%) |
| Ex-Dividend Date | Dec 27, 2023 |
| 1y Target Est | 199,714.00 |
PR NewswireAmorepacific Appoints Giovanni Valentini as CEO for the North America Region
Amorepacific is set to intensify its efforts to further accelerate growth in the North American market by appointing a new head for its operations.
PR NewswireAmorepacific Hosts NBRI Symposium
Amorepacific hosted the "New Beauty Research Initiative (NBRI) Symposium" at its R&I Center in Yongin, Korea, on Wednesday, June 5th. At this event, Amorepacific announced the findings of its skin aging research in collaboration with the Johns Hopkins University School of Medicine in the United States.
PR NewswireNew Beauty Research Initiative(NBRI) Announces Skin Epigenetics Study Findings
The results of the skin epigenetics research conducted by New Beauty Research Initiative (NBRI), operated by Amorepacific in collaboration with the Department of Dermatology at Johns Hopkins University School of Medicine, were presented at the 81st SID Annual Meeting held in Dallas, Texas, from May 15 to 17, 2024, entitled "Evaluation of epigenetic changes related to skin aging."
